The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.
"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.
'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'"
From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.
Reserve soon–only a little over a week away! Hosting over 250 senior executives, the Parks Associates Connected Health Summit spotlights health technologies as part of the Internet of Things (IoT) phe...
“The connected home has become more data hungry than ever, and video consumption is the primary driver,” says Parks Associates. “Consumers are streaming video to every available screen from an increas...
More than 25% of US smartphone owners make use of mobile payment apps at least once a month, research from Parks Associates reveals. “More than 3m retailers combined accept Apple Pay and Android Pay,...
We compare two major analyses of 2016 digital health funding, note a tender opportunity and an award in UK, and two more chapters of the Theranos Story. The ActiveProtective CEO responds to Reader and...
